Trial Profile
An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX-4975-05 Intra-articular Injection in Subjects With Chronic, Moderate-to-Severe Osteoarthritis Knee Pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Mar 2022
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary) ; Lidocaine
- Indications Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Acronyms VICTORY-3
- Sponsors Centrexion Therapeutics
- 11 Feb 2022 Status changed from active, no longer recruiting to completed.
- 16 Oct 2020 Planned End Date changed from 1 Jan 2020 to 30 Jun 2021.
- 16 Oct 2020 Planned primary completion date changed from 1 Oct 2019 to 30 Jun 2021.